TAKE THIS POLL |
|
|
- Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive 15 May 2008 21:55 GMT
... 5 Year Follow-Up for Peginterferon Alfa-2b with or without Ribavirin Is Predicted by Sustained Virologic Response at 24 Weeks Post-Treatment. Lindsay, K. et al. Poster S1001, Abstract No. 443097, ...
- Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) A 15 May 2008 20:57 GMT
... 5 Year Follow-Up for Peginterferon Alfa-2b with or without Ribavirin Is Predicted by Sustained Virologic Response at 24 Weeks Post-Treatment. Lindsay, K. et al. Poster S1001, Abstract No. 443097, ...
- Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 15 May 2008 20:44 GMT
... 5 Year Follow-Up for Peginterferon Alfa-2b with or without Ribavirin Is Predicted by Sustained Virologic Response at 24 Weeks Post-Treatment. Lindsay, K. et al. Poster S1001, Abstract No. 443097, ...
- Commonly Used Treatment of HIV Infection Effective 15 May 2008 15:55 GMT
... (Kaletra) plus two NRTIs, was significantly less efficacious (P<0.006) in terms of time to virological failure, the study found; the third regimen, a combination of efavirenz and lopinavir/ritonavir, was ...
- SeraCare Life Sciences Reports Second Quarter Fiscal Year 2008 Results 15 May 2008 14:16 GMT
... opportunities for the Company's customers. The data were presented at the 24th Annual Clinical Virology Symposium in April. -- Appointed Michael K. Steele as Vice President of Business Development. ...
- Arch Pharmalabs tie-up with Texcell SA 15 May 2008 13:57 GMT
... need to be performed under GLP (Good Laboratory Practice) compliance in pre-inspected and approved virology laboratories, explained sources. The Indian biotech industry is growing at 34.5 per cent and ...
- PEOPLE'S PHARMACY: Pomegranate juice with pectin cures 15 May 2008 09:48 GMT
... (warts on the sole of the foot). Turmeric contains curcumin, which has antiviral activity (Virology, April 10, 2008). That might explain your success. E-mail Joe and Teresa Graedon via ...
- Arch Pharmalabs inks pact with Texcell SA 15 May 2008 06:56 GMT
... need to be performed under GLP (Good Laboratory Practice) compliance in pre-inspected and approved virology laboratories. ...
- Class-Sparing Regimens for Initial Treatment of HIV-1 Infection 15 May 2008 04:42 GMT
... the three groups. Results At a median follow-up of 112 weeks, the time to virologic failure was longer in the efavirenz group than in the group (P=0.006) but was ...
- Single anti-flu drug 'not enough' 15 May 2008 01:37 GMT
... four-pronged approach, much as we tackle HIV today." Professor John Oxford, an expert in Virology at Queen Mary College School of Medicine London, said: "I don't think it should ...
- Survey sneezes up surprises 15 May 2008 00:55 GMT
... Experts say the low hygiene standards are not setting a good example for children. Virologist Dr Lance Jennings says it is concerning most people lack respiratory hygiene, especially as ...
- 09:54am Survey sneezes up surprises 15 May 2008 00:55 GMT
... Experts say the low hygiene standards are not setting a good example for children. Virologist Dr Lance Jennings says it is concerning most people lack respiratory hygiene, especially as ...
- Tamiflu may be weak defence as bird flu virus develops resistance 14 May 2008 21:29 GMT
... therapy is better than single drug therapy is not new, said Shahid Jameel, senior virologist at the International Centre for Genetic Engineering and Biotechnology in New Delhi, but the ...
- Ambrilia Biopharma Announces Positive Phase III Results - Octreotide C2L 14 May 2008 20:25 GMT
... Ambrilia’s strategy is to capitalize on its broad product portfolio and original expertise in virology. During the course of 2008, execution of the strategy aims to monetize the non-virology ...
- Kiwis lax about cold and flu hygiene 14 May 2008 20:17 GMT
... hygiene – a situation which needs attention as winter bites, according to a top virologist. A Colmar Brunton survey of 716 people aged over 18, conducted in March 2008, ...
- Roche Symposium Showcases Accomplishments of Next Generation of Chemists 14 May 2008 19:49 GMT
... the leading supplier of medicines for cancer and transplantation and a market leader in virology. Located in Palo Alto, Calif., Roche Palo Alto LLC is one of the company's ...
- Use a tissue, a tissue or we all fall down... 14 May 2008 17:43 GMT
... the flu. Such practices are not setting a good example for children, according to virologist Dr Lance Jennings. He said colds and flus were debilitating, especially for children, and ...
- Microbix Makes Significant Progress in Implementing Strategic Plan in ... 14 May 2008 17:08 GMT
... and we expect to reach important milestones with SST(TM)in the coming months. Our base Virology business continues to support our pipeline development activities with strong cash flows from this ...
- Microbix Makes Significant Progress in Implementing Strategic Plan in Q2 14 May 2008 16:45 GMT
... and we expect to reach important milestones with SST(TM)in the coming months. Our base Virology business continues to support our pipeline development activities with strong cash flows from this ...
- Cervarix(TM) Demonstrates 100 per cent Efficacy with Longest Duration of Sustained Neutralizing Antibodies to date 14 May 2008 15:50 GMT
... 303 - 315.) 7 De Villiers EM. Heterogeneity of the human papillomavirus group. J Virology 1989; 63: 4898-903. 4. 796-802 8 Munoz N, Bosch X, Castellasague X. Against which ...
- Researchers discover long-suspected HIV hideout in huma... 14 May 2008 15:11 GMT
... the cell can get destroyed in the process," said Burton. Suzanne Gartner, an HIV virologist at Hopkins, and Burton devised a method of getting into the FDCs, which involves ...
- Researchers Get Inside A Long Suspected HIV Hideout In Humans 14 May 2008 13:35 GMT
... Foundation for AIDS Research, will appear in the June issue of the Journal of Virology . "One of the biggest obstacles in treating patients with HIV is the establishment ...
- Ambrilia Reports Positive Final Phase III Results for its Octreotide Formulation C2L - 24-week results support the ability of C2L to replace Sandostatin(R)LAR with less frequent injections and non-inferior efficacy - Expanded dive 14 May 2008 13:17 GMT
... Ambrilia's strategy is to capitalize on its broad product portfolio and original expertise in virology. During the course of 2008, execution of the strategy aims to monetize the non-virology ...
- Ambrilia Reports First Quarter 2008 Results 14 May 2008 12:53 GMT
... The strategy aims to capitalize on the Company's broad portfolio and original expertise in virology. Today, Ambrilia's product portfolio is comprised of oncology and antiviral assets, including two new ...
- Researchers discover long-suspected HIV hideout in humans 14 May 2008 12:13 GMT
... the cell can get destroyed in the process," said Burton. Suzanne Gartner, an HIV virologist at Hopkins, and Burton devised a method of getting into the FDCs, which involves ...
1 - 25 of 121 next >
News by PR Newswire
|
